Target intelligence / Profile preview

Enterovirus A capsid surface protein (VP1–VP3)

Molecular classification
Other (Viral capsid protein)
01

Overview

The surface proteins VP1, VP2, and VP3 of Enterovirus 71, Coxsackievirus A16, Coxsackievirus A10, and Coxsackievirus A6 form the outer shell of the viral capsid, which protects the viral RNA and mediates attachment and entry into host cells. These proteins assemble into icosahedral particles and display variable surface loops that define antigenic properties and receptor interactions. VP1, in particular, contains key neutralizing epitopes and forms the so-called “canyon” used for receptor engagement. Structural differences, especially in surface loops, help determine host range and immune escape; thus, they are the primary targets for vaccine and therapeutic antibody development. Capsid-binding small molecules also target conserved pockets in these proteins to block viral uncoating and entry. The antigenic and structural diversity between these viruses complicates broad-spectrum drug and vaccine development[2][3][4][6].

Other names
Enterovirus capsid proteinVP1VP2VP3viral capsid protein
02

Mechanism of action

Inhibition of viral uncoating (capsid binders stabilize capsid)[2]; Virus neutralization (by antibody binding to critical epitopes)[4]

03

Biological functions

Virion assemblyHost cell recognitionHost cell entry (mediates receptor binding and fusion)Elicitation of host immune response (primary antigenic determinants)
04

Disease associations

Infection (Hand, foot, and mouth disease; neurological complications)
05

Safety considerations

Antigenic variation among surface loops reduces efficacy of antibodies and drugs[2][3]Potential for immune escape, vaccine mismatches, or incomplete cross-protection[3][4]
06

Interacting drugs

Pleconaril (broad-spectrum capsid binder, not approved)

2 more in the full profile.

07

Biomarkers

Serum neutralizing antibody titers against VP1 or whole virion[3][4]

Beyond the preview

Go deeper on Enterovirus A capsid surface protein (VP1–VP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterovirus A capsid surface protein (VP1–VP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call